Previous Article | Next Article 
Journal of Virology, August 2000, p. 6712-6719, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Herpes Simplex Virus Type 1 Glycoprotein E Domains
Involved in Virus Spread and Disease
Charles E.
Saldanha,1,
John
Lubinski,1
Claudia
Martin,1,
Thandavarayan
Nagashunmugam,1,§
Liyang
Wang,1,
Harjeet
van
der Keyl,2
Ruth
Tal-Singer,2 and
Harvey M.
Friedman1,*
Division of Infectious Diseases, Department
of Medicine, University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania 19104-6073,1 and
SmithKline Beecham Pharmaceuticals, UP1455, Collegeville,
Pennsylvania 19426-09892
Received 4 February 2000/Accepted 2 May 2000
Herpes simplex virus type 1 (HSV-1) glycoprotein E (gE) functions
as an immunoglobulin G (IgG) Fc binding protein and is involved in
virus spread. Previously we studied a gE mutant virus that was impaired
for IgG Fc binding but intact for spread and another that was normal
for both activities. To further evaluate the role of gE in spread, two
additional mutant viruses were constructed by introducing linker
insertion mutations either outside the IgG Fc binding domain
at gE position 210 or within the IgG Fc binding domain at position 380. Both mutant viruses were impaired for spread in epidermal cells in
vitro; however, the 380 mutant virus was significantly more impaired
and was as defective as gE null virus. gE mutant viruses were
inoculated into the murine flank to measure epidermal disease at the
inoculation site, travel of virus to dorsal root ganglia, and spread of
virus from ganglia back to skin to produce zosteriform lesions. Disease
at the inoculation and zosteriform sites was reduced for both
mutant viruses, but more so for the 380 mutant virus. Moreover, the 380 mutant virus was highly impaired in its ability to reach the ganglia,
as demonstrated by virus culture and real-time quantitative
PCR. The results indicate that the domain surrounding amino acid 380 is
important for both spread and IgG Fc binding and suggest that this
domain is a potential target for antiviral therapy or vaccines.
*
Corresponding author. Mailing address: 536 Johnson
Pavilion, University of Pennsylvania, Philadelphia, PA 19104-6073. Phone: (215) 662-3557. Fax: (215) 349-5111. E-mail:
hfriedma{at}mail.med.upenn.edu.

Present address: Department of Medicine, Brigham and Women's
Hospital, Boston, MA
02115.

Present address: Seattle, WA
98103.
§
Present address: Shared Medical Systems, Malvern, PA
19355.

Present address: CNS/Pharmacology Department, Schering
Plough, Kenilworth, NJ
07033.
Journal of Virology, August 2000, p. 6712-6719, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
McGraw, H. M., Awasthi, S., Wojcechowskyj, J. A., Friedman, H. M.
(2009). Anterograde Spread of Herpes Simplex Virus Type 1 Requires Glycoprotein E and Glycoprotein I but Not Us9. J. Virol.
83: 8315-8326
[Abstract]
[Full Text]
-
McGraw, H. M., Friedman, H. M.
(2009). Herpes Simplex Virus Type 1 Glycoprotein E Mediates Retrograde Spread from Epithelial Cells to Neurites. J. Virol.
83: 4791-4799
[Abstract]
[Full Text]
-
Brittle, E. E., Wang, F., Lubinski, J. M., Bunte, R. M., Friedman, H. M.
(2008). A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine. J. Virol.
82: 8431-8441
[Abstract]
[Full Text]
-
Farnsworth, A., Johnson, D. C.
(2006). Herpes Simplex Virus gE/gI Must Accumulate in the trans-Golgi Network at Early Times and Then Redistribute to Cell Junctions To Promote Cell-Cell Spread.. J. Virol.
80: 3167-3179
[Abstract]
[Full Text]
-
Wang, F., Tang, W., McGraw, H. M., Bennett, J., Enquist, L. W., Friedman, H. M.
(2005). Herpes Simplex Virus Type 1 Glycoprotein E Is Required for Axonal Localization of Capsid, Tegument, and Membrane Glycoproteins. J. Virol.
79: 13362-13372
[Abstract]
[Full Text]
-
Polcicova, K., Goldsmith, K., Rainish, B. L., Wisner, T. W., Johnson, D. C.
(2005). The Extracellular Domain of Herpes Simplex Virus gE Is Indispensable for Efficient Cell-to-Cell Spread: Evidence for gE/gI Receptors. J. Virol.
79: 11990-12001
[Abstract]
[Full Text]
-
Brittle, E. E., Reynolds, A. E., Enquist, L. W.
(2004). Two Modes of Pseudorabies Virus Neuroinvasion and Lethality in Mice. J. Virol.
78: 12951-12963
[Abstract]
[Full Text]
-
Bhuyan, P. K., Kariko, K., Capodici, J., Lubinski, J., Hook, L. M., Friedman, H. M., Weissman, D.
(2004). Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes. J. Virol.
78: 10276-10281
[Abstract]
[Full Text]
-
Lin, X., Lubinski, J. M., Friedman, H. M.
(2004). Immunization Strategies To Block the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor. J. Virol.
78: 2562-2571
[Abstract]
[Full Text]
-
Mador, N., Braun, E., Haim, H., Ariel, I., Panet, A., Steiner, I.
(2003). Transgenic Mouse with the Herpes Simplex Virus Type 1 Latency-Associated Gene: Expression and Function of the Transgene. J. Virol.
77: 12421-12429
[Abstract]
[Full Text]
-
Lubinski, J. M., Jiang, M., Hook, L., Chang, Y., Sarver, C., Mastellos, D., Lambris, J. D., Cohen, G. H., Eisenberg, R. J., Friedman, H. M.
(2002). Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo. J. Virol.
76: 9232-9241
[Abstract]
[Full Text]
-
Mackay, I. M., Arden, K. E., Nitsche, A.
(2002). Real-time PCR in virology. Nucleic Acids Res
30: 1292-1305
[Abstract]
[Full Text]
-
Loutsch, J. M., Sainz, B. Jr., Marquart, M. E., Zheng, X., Kesavan, P., Higaki, S., Hill, J. M., Tal-Singer, R.
(2001). Effect of Famciclovir on Herpes Simplex Virus Type 1 Corneal Disease and Establishment of Latency in Rabbits. Antimicrob. Agents Chemother.
45: 2044-2053
[Abstract]
[Full Text]